Northern Trust’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.2M | Buy |
315,246
+278,322
| +754% | +$14.4M | ﹤0.01% | 1800 |
|
|
2026
Q1 | $1.78M | Sell |
36,924
-23,373
| -39% | -$1.04M | ﹤0.01% | 3034 |
|
|
2025
Q4 | $2.49M | Buy |
60,297
+7,890
| +15% | +$317K | ﹤0.01% | 2869 |
|
|
2025
Q3 | $2.03M | Sell |
52,407
-2,180
| -4% | -$70.8K | ﹤0.01% | 3029 |
|
|
2025
Q2 | $1.51M | Sell |
54,587
-236,609
| -81% | -$6.02M | ﹤0.01% | 3159 |
|
|
2025
Q1 | $6.47M | Buy |
291,196
+7,597
| +3% | +$156K | ﹤0.01% | 2285 |
|
|
2024
Q4 | $5.61M | Buy |
283,599
+28,393
| +11% | +$648K | ﹤0.01% | 2444 |
|
|
2024
Q3 | $6.38M | Sell |
255,206
-37,727
| -13% | -$919K | ﹤0.01% | 2342 |
|
|
2024
Q2 | $5.47M | Buy |
292,933
+2,289
| +0.8% | +$42.9K | ﹤0.01% | 2345 |
|
|
2024
Q1 | $5.73M | Sell |
290,644
-9,480
| -3% | -$185K | ﹤0.01% | 2371 |
|
|
2023
Q4 | $5.26M | Buy |
300,124
+4,005
| +1% | +$65.8K | ﹤0.01% | 2484 |
|
|
2023
Q3 | $5.14M | Buy |
296,119
+7,842
| +3% | +$132K | ﹤0.01% | 2423 |
|
|
2023
Q2 | $4.06M | Sell |
288,277
-3,843
| -1% | -$51.4K | ﹤0.01% | 2614 |
|
|
2023
Q1 | $3.14M | Buy |
292,120
+5,445
| +2% | +$71.7K | ﹤0.01% | 2729 |
|
|
2022
Q4 | $4.29M | Buy |
286,675
+15,241
| +6% | +$222K | ﹤0.01% | 2578 |
|
|
2022
Q3 | $3.49M | Sell |
271,434
-3,871
| -1% | -$44.1K | ﹤0.01% | 2707 |
|
|
2022
Q2 | $2.67M | Buy |
275,305
+7,260
| +3% | +$67.7K | ﹤0.01% | 2895 |
|
|
2022
Q1 | $2.66M | Sell |
268,045
-12,587
| -4% | -$133K | ﹤0.01% | 2950 |
|
|
2021
Q4 | $3.3M | Buy |
280,632
+6,074
| +2% | +$74.6K | ﹤0.01% | 2957 |
|
|
2021
Q3 | $3.13M | Sell |
274,558
-11,640
| -4% | -$152K | ﹤0.01% | 3035 |
|
|
2021
Q2 | $3.99M | Sell |
286,198
-13,117
| -4% | -$199K | ﹤0.01% | 2977 |
|
|
2021
Q1 | $5.54M | Sell |
299,315
-13,687
| -4% | -$280K | ﹤0.01% | 2685 |
|
|
2020
Q4 | $5.53M | Sell |
313,002
-1,410
| -0.4% | -$24.8K | ﹤0.01% | 2631 |
|
|
2020
Q3 | $4.82M | Buy |
314,412
+77,402
| +33% | +$1.45M | ﹤0.01% | 2553 |
|
|
2020
Q2 | $6.04M | Buy |
237,010
+60,794
| +34% | +$1.27M | ﹤0.01% | 2403 |
|
|
2020
Q1 | $2.73M | Buy |
176,216
+28,008
| +19% | +$438K | ﹤0.01% | 2670 |
|
|
2019
Q4 | $1.64M | Sell |
148,208
-15,305
| -9% | -$133K | ﹤0.01% | 3228 |
|
|
2019
Q3 | $1.39M | Buy |
163,513
+8,614
| +6% | +$95.2K | ﹤0.01% | 3276 |
|
|
2019
Q2 | $2.1M | Buy |
154,899
+22,645
| +17% | +$351K | ﹤0.01% | 3053 |
|
|
2019
Q1 | $2.39M | Buy |
132,254
+53,670
| +68% | +$1.04M | ﹤0.01% | 2965 |
|
|
2018
Q4 | $2.21M | Sell |
78,584
-358
| -0.5% | -$7.47K | ﹤0.01% | 2992 |
|
|
2018
Q3 | $2.01M | Buy |
+78,942
| New | +$1.53M | ﹤0.01% | 3210 |
|
Other funds holding KNSA
RCMNY
BBA
TCM
SSC
Northern Trust's KNSA Position: Q2 2026 in Review
Northern Trust increased its Kiniksa Pharmaceuticals (KNSA) stake by 754% in Q2 2026, buying an estimated $14.4M and bringing the position to 315,246 shares worth $20.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1800.
Northern Trust first reported a position in KNSA in Q3 2018 and has held it in 32 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.
- Northern Trust held 315,246 shares of Kiniksa Pharmaceuticals worth $20.2M as of Q2 2026.
- Northern Trust bought 278,322 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $14.4M.
- Kiniksa Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1800 holding.
- Northern Trust first reported a position in Kiniksa Pharmaceuticals in Q3 2018 and has held it in 32 quarters since.
- 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.